HAUGHEY THOMAS

SEC Form 4 insider trading activity

HAUGHEY THOMAS has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 11, 2026.

On the most recent filing, HAUGHEY THOMAS is listed as Director at ANI PHARMACEUTICALS INC. Inside the rolling window, HAUGHEY THOMAS reported no open-market purchases and 1 open-market sale totaling $162K in ANIP.

Companies traded

Other insiders at ANIP

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$162K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ANIP
HAUGHEY THOMAS
Sale$162KJun 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has HAUGHEY THOMAS made?

HAUGHEY THOMAS has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.

Which companies does HAUGHEY THOMAS trade?

HAUGHEY THOMAS has filed SEC Form 4 disclosures for 1 company, including ANIP.

When was HAUGHEY THOMAS's most recent SEC Form 4 filing?

HAUGHEY THOMAS's most recent SEC Form 4 filing on Tracefour is dated Jun 11, 2026.

What is HAUGHEY THOMAS's total buy and sell value in the current window?

Inside the rolling retention window, HAUGHEY THOMAS bought $0 and sold $162K based on SEC Form 4 filings.

What was HAUGHEY THOMAS's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 2,000 ANIP shares on 2026-06-08, worth $162K, per SEC Form 4 filings.